Cargando…
Paradoxes in thyroid carcinoma treatment: analysis of the SEER database 2010—2013
Thyroid cancer is a common malignant disease with high survival rate (98.1%, 2006-2012, Surveillance Epidemiology and End Results (SEER) program). In this study, we investigated the treatment paradoxes in thyroid T0 and micro-carcinoma patients. 48,234 thyroid carcinoma patients were identified from...
Autores principales: | Zhou, Ping, Tian, Shuangming, Li, Jiale, Zhao, Yongfeng, Liu, Wengang, Zhang, Yan, Hu, Zheyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352124/ https://www.ncbi.nlm.nih.gov/pubmed/27861148 http://dx.doi.org/10.18632/oncotarget.13395 |
Ejemplares similares
-
Antitumor activity of integrin α(V)β(3) antibody conjugated-cationic microbubbles in liver cancer
por: Li, Jiale, et al.
Publicado: (2019) -
Superb Microvascular Imaging Compared with Contrast-Enhanced Ultrasound for Assessing Laser Ablation Treatment of Benign Thyroid Nodules
por: Liu, Wengang, et al.
Publicado: (2018) -
Unanticipated prognosis of differential thyroid cancer patients with T0 stage: analysis of the SEER database 2004-2013
por: Liu, Chunping, et al.
Publicado: (2017) -
Is biopsy enough for papillary thyroid microcarcinoma?: An analysis of the SEER database 2004 to 2013 with propensity score matching
por: Liu, Zeming, et al.
Publicado: (2018) -
Correction: Unanticipated prognosis of differential thyroid cancer patients with T0 stage: analysis of the SEER database 2004-2013
por: Liu, Chunping, et al.
Publicado: (2018)